HIGGINS JOHN L Insider Trading
Get the latest insider transactions of HIGGINS JOHN L. HIGGINS JOHN L is Chief Executive Officer in LIGAND PHARMACEUTICALS INC ($LGND) and in BIO-TECHNE Corp ($TECH) and Director in BIO-TECHNE Corp ($TECH) and EVP, Finance, Corp Dev. & CFO in CONNETICS CORP ($CNCT). Discover the current value of HIGGINS JOHN L shares.
Address: 3290 W. BAYSHORE ROAD PALO ALTO 94303CA
HIGGINS JOHN L is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
CNCT | CONNETICS CORP | EVP, Finance, Corp Dev. & CFO | 81,195 | 0.00 |
TECH | BIO-TECHNE Corp | 9,412 | 952,306.16 | |
LGND | LIGAND PHARMACEUTICALS INC | Chief Executive Officer | 340,696 | 36,740,656.64 |
Insider Trading Transactions of HIGGINS JOHN L
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Feb 09 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 14.47 | 54,666 | 791,017 | 340,696 |
Feb 09 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 203.40 | 54,666 | 11,119,239 | 286,030 |
Feb 09 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 10.05 | 60,000 | 603,000 | 346,030 |
Feb 09 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 203.03 | 2,970 | 602,999 | 343,060 |
Feb 09 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 10.05 | 60,000 | 603,000 | 0 |
Feb 09 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 14.47 | 54,666 | 791,017 | 14,334 |
Feb 05 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 12,608 | 0 | 286,030 |
Feb 05 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 177.50 | 25,113 | 4,457,558 | 25,113 |
Jan 27 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 14.47 | 50,000 | 723,500 | 285,310 |
Jan 27 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 159.00 | 50,000 | 7,950,000 | 235,310 |
Jan 27 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 5,946 | 0 | 241,256 |
Jan 27 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 156.01 | 2,845 | 443,848 | 238,411 |
Jan 27 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 9,607 | 0 | 248,018 |
Jan 27 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 156.01 | 4,596 | 717,022 | 243,422 |
Jan 27 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 14.47 | 40,000 | 578,800 | 283,422 |
Jan 27 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 182.00 | 40,000 | 7,280,000 | 243,422 |
Jan 27 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 21.92 | 30,000 | 657,600 | 273,422 |
Jan 27 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 14.47 | 50,000 | 723,500 | 109,000 |
Jan 27 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 14.47 | 40,000 | 578,800 | 69,000 |
Jan 27 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 21.92 | 30,000 | 657,600 | 65,616 |
Jan 05 2021 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 84.53 | 223 | 18,851 | 235,310 |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Buy | 70.35 | 5,000 | 351,750 | 9,412 | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | 298.98 | 1,450 | 433,516 | 7,962 | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | 299.84 | 450 | 134,928 | 7,512 | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | 301.07 | 3,100 | 933,301 | 4,412 | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | 70.35 | 5,000 | 351,750 | 0 | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Buy | 70.35 | 5,000 | 351,750 | 9,412 | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | 298.98 | 1,450 | 433,516 | 7,962 | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | 299.84 | 450 | 134,928 | 7,512 | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | 301.07 | 3,100 | 933,301 | 4,412 | |
Nov 10 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | 70.35 | 5,000 | 351,750 | 0 | |
Nov 02 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Buy | 0.00 | 391 | 0 | 4,412 | |
Nov 02 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | 255.69 | 1,507 | 385,325 | 1,507 | |
Jul 09 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 85.79 | 1,165 | 99,945 | 201,421 |
Jul 09 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 56.26 | 1,777 | 99,974 | 203,198 |
Jul 09 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 74.42 | 1,373 | 102,179 | 204,571 |
Jul 09 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 56.26 | 1,777 | 99,974 | 54,421 |
Jul 09 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 74.42 | 1,373 | 102,179 | 93,627 |
Jul 09 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 85.79 | 1,165 | 99,945 | 54,226 |
Apr 24 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 120.86 | 1,918 | 231,809 | 136,981 |
Apr 24 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 120.86 | 1,689 | 204,133 | 135,292 |
Apr 24 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 120.86 | 1,310 | 158,327 | 133,982 |
Feb 18 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 9.96 | 48,125 | 479,325 | 201,739 |
Feb 18 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 95.68 | 5,009 | 479,261 | 196,730 |
Feb 18 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 13,559 | 0 | 210,289 |
Feb 18 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 97.23 | 1,689 | 164,221 | 208,600 |
Feb 18 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 97.23 | 1,310 | 127,371 | 207,290 |
Feb 18 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 97.23 | 2,117 | 205,836 | 205,173 |
Feb 18 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 95.68 | 60,886 | 5,825,572 | 60,886 |
Feb 18 2020 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 9.96 | 48,125 | 479,325 | 0 |
Feb 14 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Buy | 61.46 | 5,000 | 307,300 | 9,021 |
Feb 14 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Sell | 205.23 | 5,000 | 1,026,133 | 4,021 |
Feb 14 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Option Exercise | 61.46 | 5,000 | 307,300 | 0 |
Dec 26 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 7,668 | 0 | 154,417 |
Dec 26 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 105.87 | 3,801 | 402,412 | 150,616 |
Dec 26 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 5,946 | 0 | 156,562 |
Dec 26 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 105.87 | 2,948 | 312,105 | 153,614 |
Oct 28 2019 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Buy | 0.00 | 495 | 0 | 4,021 |
Oct 28 2019 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Option Exercise | 201.64 | 2,011 | 405,498 | 2,011 |
Jul 31 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 95.45 | 1,850 | 176,583 | 146,749 |
Jun 06 2019 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Buy | 63.03 | 5,000 | 315,150 | 8,526 | |
Jun 06 2019 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Sell | 203.67 | 5,000 | 1,018,346 | 3,526 | |
Jun 06 2019 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | 63.03 | 5,000 | 315,150 | 0 | |
May 31 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 108.20 | 1,000 | 108,202 | 144,899 |
May 31 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 108.20 | 1,000 | 108,202 | 144,899 |
May 14 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 113.50 | 2,500 | 283,750 | 143,899 |
Mar 15 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 114.29 | 2,500 | 285,725 | 141,399 |
Jan 25 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 7,256 | 0 | 126,465 |
Jan 25 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 111.78 | 3,597 | 402,073 | 122,868 |
Jan 25 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 6,390 | 0 | 129,258 |
Jan 25 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 111.78 | 3,168 | 354,119 | 126,090 |
Jan 14 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 16.14 | 4,000 | 64,560 | 89,419 |
Jan 14 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 16.14 | 29,790 | 480,811 | 119,209 |
Jan 14 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 16.14 | 29,790 | 480,811 | 0 |
Jan 14 2019 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 16.14 | 4,000 | 64,560 | 0 |
Oct 29 2018 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Buy | 0.00 | 514 | 0 | 3,526 | |
Oct 29 2018 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | 179.84 | 1,898 | 341,336 | 1,898 | |
Aug 31 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 258.25 | 3,500 | 903,875 | 85,419 |
Aug 27 2018 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Buy | 61.08 | 10,000 | 610,800 | 13,012 |
Aug 27 2018 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Sell | 187.92 | 10,000 | 1,879,173 | 3,012 |
Aug 27 2018 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Option Exercise | 61.08 | 10,000 | 610,800 | 0 |
Aug 17 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 14.47 | 3,007 | 43,511 | 110,426 |
Aug 17 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 241.33 | 21,507 | 5,190,261 | 88,919 |
Aug 17 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 14.47 | 12,993 | 188,009 | 101,912 |
Aug 17 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 243.00 | 12,993 | 3,157,299 | 88,919 |
Aug 17 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 14.47 | 3,007 | 43,511 | 171,993 |
Aug 17 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 14.47 | 12,993 | 188,009 | 159,000 |
May 15 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 16.14 | 12,405 | 200,217 | 119,824 |
May 15 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 179.97 | 12,405 | 2,232,491 | 107,419 |
May 15 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 16.14 | 12,405 | 200,217 | 29,790 |
Mar 06 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 7,928 | 0 | 104,386 |
Mar 06 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 6,015 | 0 | 110,401 |
Mar 06 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 165.87 | 2,982 | 494,624 | 107,419 |
Mar 06 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 159.01 | 41,392 | 6,581,742 | 41,392 |
Feb 16 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 157.03 | 9,000 | 1,413,279 | 102,700 |
Feb 16 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 157.18 | 2,635 | 414,169 | 100,065 |
Feb 16 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 157.18 | 1,918 | 301,471 | 98,147 |
Feb 16 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 157.18 | 1,689 | 265,477 | 96,458 |
Jan 26 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 165.00 | 22,500 | 3,712,500 | 111,700 |
Jan 22 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 16.14 | 16,249 | 262,259 | 162,299 |
Jan 22 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 155.00 | 16,249 | 2,518,595 | 146,050 |
Jan 22 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 151.93 | 11,850 | 1,800,307 | 134,200 |
Jan 22 2018 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 16.14 | 16,249 | 262,259 | 42,195 |
Dec 29 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 9,965 | 0 | 151,249 |
Dec 29 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 138.66 | 5,199 | 720,893 | 146,050 |
Nov 20 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 140.34 | 2,258 | 316,888 | 141,284 |
Nov 17 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 142.53 | 5,269 | 750,991 | 143,542 |
Oct 30 2017 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Buy | 0.00 | 739 | 0 | 3,012 | |
Oct 30 2017 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | 125.05 | 3,125 | 390,781 | 3,125 | |
Oct 17 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 21.92 | 11,384 | 249,537 | 150,555 |
Oct 17 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 143.04 | 1,744 | 249,462 | 148,811 |
Oct 17 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 21.92 | 11,384 | 249,537 | 0 |
Sep 06 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 21.00 | 5,000 | 105,000 | 144,171 |
Sep 06 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 130.00 | 5,000 | 650,000 | 139,171 |
Sep 06 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 21.00 | 5,000 | 105,000 | 0 |
Aug 10 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 21.00 | 5,483 | 115,143 | 144,654 |
Aug 10 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 125.00 | 5,483 | 685,375 | 139,171 |
Aug 10 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 21.00 | 5,483 | 115,143 | 5,000 |
Jun 23 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 21.00 | 4,666 | 97,986 | 143,837 |
Jun 23 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 120.00 | 4,666 | 559,920 | 139,171 |
Jun 23 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 21.00 | 4,666 | 97,986 | 4,666 |
Jun 23 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 21.00 | 4,666 | 97,986 | 0 |
Jun 09 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 21.00 | 12,000 | 252,000 | 151,171 |
Jun 09 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 114.87 | 12,000 | 1,378,440 | 139,171 |
Jun 09 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 21.00 | 12,000 | 252,000 | 10,483 |
Mar 21 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 109.10 | 4,000 | 436,400 | 139,171 |
Mar 10 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 107.06 | 4,000 | 428,240 | 128,969 |
Mar 10 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 10.05 | 15,675 | 157,534 | 144,644 |
Mar 10 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 106.92 | 1,473 | 157,493 | 143,171 |
Mar 10 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 10.05 | 15,675 | 157,534 | 0 |
Feb 28 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 104.28 | 2,285 | 238,280 | 120,379 |
Feb 28 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 104.28 | 2,019 | 210,541 | 118,360 |
Feb 28 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 9,168 | 0 | 127,528 |
Feb 28 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 100.38 | 4,783 | 480,118 | 122,745 |
Feb 28 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 10,224 | 0 | 132,969 |
Feb 28 2017 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 100.38 | 43,646 | 4,381,185 | 43,646 |
Oct 31 2016 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Buy | 0.00 | 914 | 0 | 2,273 |
Oct 31 2016 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Option Exercise | 101.19 | 3,985 | 403,242 | 3,985 |
Sep 23 2016 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 117.34 | 3,000 | 352,020 | 122,664 |
Sep 12 2016 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Sell | 109.83 | 1,700 | 186,716 | 1,359 |
Mar 09 2016 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 102.44 | 10,277 | 1,052,776 | 120,220 |
Mar 09 2016 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 102.97 | 556 | 57,251 | 119,664 |
Mar 09 2016 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 21.00 | 6,000 | 126,000 | 125,664 |
Mar 09 2016 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 21.00 | 6,000 | 126,000 | 22,483 |
Feb 16 2016 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Buy | 0.00 | 11,611 | 0 | 132,989 |
Feb 16 2016 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 85.97 | 2,492 | 214,237 | 130,497 |
Feb 16 2016 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Option Exercise | 85.79 | 55,391 | 4,751,994 | 55,391 |
Nov 02 2015 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Buy | 0.00 | 1,059 | 0 | 3,059 | |
Nov 02 2015 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Option Exercise | 87.34 | 4,260 | 372,068 | 4,260 | |
Aug 07 2015 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 110.79 | 4,666 | 516,946 | 121,378 |
Jun 11 2015 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 92.53 | 6,200 | 573,686 | 129,844 |
Jun 11 2015 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 93.21 | 3,300 | 307,593 | 126,544 |
Jun 11 2015 | LGND | LIGAND PHARMACEUTICALS IN ... | HIGGINS JOHN L | Chief Executive Offic ... | Sell | 95.06 | 500 | 47,530 | 126,044 |
Mar 16 2004 | CNCT | CONNETICS CORP | HIGGINS JOHN L | EVP, Finance, Corp De ... | Buy | 8.75 | 5,000 | 43,750 | 86,195 |
Mar 16 2004 | CNCT | CONNETICS CORP | HIGGINS JOHN L | EVP, Finance, Corp De ... | Sell | 22.36 | 5,000 | 111,819 | 81,195 |
Mar 16 2004 | CNCT | CONNETICS CORP | HIGGINS JOHN L | EVP, Finance, Corp De ... | Option Exercise | 8.75 | 5,000 | 43,750 | 496,232 |
Feb 23 2004 | CNCT | CONNETICS CORP | HIGGINS JOHN L | EVP, Finance, Corp De ... | Buy | 4.31 | 23,378 | 100,818 | 83,426 |
Feb 23 2004 | CNCT | CONNETICS CORP | HIGGINS JOHN L | EVP, Finance, Corp De ... | Buy | 6.38 | 3,579 | 22,816 | 87,005 |
Feb 23 2004 | CNCT | CONNETICS CORP | HIGGINS JOHN L | EVP, Finance, Corp De ... | Sell | 21.28 | 5,810 | 123,637 | 81,195 |
Feb 23 2004 | CNCT | CONNETICS CORP | HIGGINS JOHN L | EVP, Finance, Corp De ... | Option Exercise | 4.31 | 23,378 | 100,818 | 504,811 |
Feb 23 2004 | CNCT | CONNETICS CORP | HIGGINS JOHN L | EVP, Finance, Corp De ... | Option Exercise | 6.38 | 3,579 | 22,816 | 501,232 |
Feb 11 2004 | CNCT | CONNETICS CORP | HIGGINS JOHN L | EVP, Finance, Corp De ... | Buy | 8.75 | 15,000 | 131,250 | 75,048 |
Feb 11 2004 | CNCT | CONNETICS CORP | HIGGINS JOHN L | EVP, Finance, Corp De ... | Sell | 25.20 | 15,000 | 377,970 | 60,048 |
Feb 11 2004 | CNCT | CONNETICS CORP | HIGGINS JOHN L | EVP, Finance, Corp De ... | Option Exercise | 8.75 | 15,000 | 131,250 | 528,189 |